Anti-FKN mAb E6011 inhibited recruitment immune cells by blocking the FKN–CX3CR1 axis, which was expected to be useful for Crohn’s disease (CD), RA, and PBC (97). Here, CX3CR1 is linked to primary biliary cholangitis.